ASCO GI Webinar Update on NET and HCC_Ipsen

ASCO GI Webinar: Update on NET and HCC

At the Virtual Scientific Symposium on Gastrointestinal Cancers held on the 20th of March 2021, Dr Roland Leung and Dr Thomas Yau presented updates from ESMO 2020 and ASCO GI 2021 with a focus on gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and hepatocellular carcinoma (HCC), respectively.
detecting metastases with psma pet in prostate cancer

Detecting metastases with PSMA-PET in prostate cancer

Conventional imaging with computed tomography (CT), magnetic resonance imaging (MRI) and bone scans, are the current standard of care for imaging prostate cancer. Accurate imaging primarily relies on nodal metastases size for detection.
Combination therapy with a novel agent, albuvirtide, in hospitalised AIDs patients

Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients

Delayed therapy start and antiretroviral therapy (ART) resistance are two common issues affecting up to 33% and 17% of patients infected with human immunodeficiency virus (HIV), respectively. These patients commonly present with higher viral loads, lower CD4 T-cell count, and complications such as infections requiring acute treatment. For those patients presenting with acquired immunodeficiency syndrome (AIDS) or those who have breakthrough HIV, and who present with opportunistic infections and comorbidities requiring hospitalisation, ART treatments are limited.
CANCERINFORMER
BREAKING

Therapeutic Areas

Or, sign up for our newsletter


Therapeutic Areas

ASCO GI Webinar Update on NET and HCC_Ipsen

ASCO GI Webinar: Update on NET and HCC

At the Virtual Scientific Symposium on Gastrointestinal Cancers held on the 20th of March 2021, Dr Roland Leung and Dr Thomas Yau presented updates from ESMO 2020 and ASCO GI 2021 with a focus on gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and hepatocellular carcinoma (HCC), respectively.
Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

Patient blood management (PBM) is a multimodal, multidisciplinary, patient-centred strategy aimed at minimising the use of blood products and improving patient outcomes. It has shown to minimise perioperative bleeding, perioperative morbidity, mortality and duration of hospitalisation. There are three main pillars of PBM – improving red cell mass, minimising blood loss, and managing anaemia.
Copy link
Powered by Social Snap
MediPaper Medical Communications Agency Hong Kong Blog